Evidence map›Paper›PMID 29192235›Full record

ArticleNature communications2017

Multiplex single-cell visualization of nucleic acids and protein during HIV infection.

Maritza Puray-Chavez, Philip R Tedbury, Andrew D Huber, Obiaara B Ukah, Vincent Yapo, Dandan Liu, Juan Ji, Jennifer J Wolf, Alan N Engelman, Stefan G Sarafianos

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. A fastFly · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Maritza Puray-ChavezCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Philip R TedburyCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Andrew D HuberCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Obiaara B UkahCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Vincent YapoCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Dandan LiuCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Juan JiCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Jennifer J WolfCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
Alan N EngelmanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Stefan G SarafianosCS Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA. sarafianoss@missouri.edu.
University of Missouri · USDana-Farber Cancer Institute · USEmory University · US

Funding

Project 9P50GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ARNOLD, EDWARD · 2012 to 2016
$20.0M
Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
X-ray Crystallographic Fragment Screening CoreU54GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SARAFIANOS, STEFAN G, TORBETT, BRUCE EDWARD · 2017 to 2018
$11.1M
MINORITY BIOMEDICAL RESEARCHERS TRAINING INITIATIVER25GM056901 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI HANNINK, MARK · 1999 to 2019
$8.4M
Structural studies of HIV Capsid with host factors and Capsid-targeting antiviralsR01AI120860 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI Stefan G Sarafianos, Zhengqiang Wang · 2015 to 2026
$6.0M
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIVR01AI076119 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI SARAFIANOS, STEFAN G · 2008 to 2018
$4.1M
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIVR37AI076119 · NIAID · EMORY UNIVERSITY · PI Stefan G Sarafianos · 2020 to 2026
$3.6M
Novel antivirals targeting the RNase H activity of HIV reverse transcriptaseR01AI100890 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI SARAFIANOS, STEFAN G, WANG, ZHENGQIANG · 2012 to 2016
$3.6M
NIAID NIH HHS R01 AI052014NIAID NIH HHS R01 AI076119NIAID NIH HHS R01 AI100890NIAID NIH HHS R01 AI120860NIAID NIH HHS R37 AI076119NIGMS NIH HHS P50 GM103368NIGMS NIH HHS R25 GM056901NIGMS NIH HHS U54 GM103368
6 · The paper itself

Abstract

Technical limitations in simultaneous microscopic visualization of RNA, DNA, and proteins of HIV have curtailed progress in this field. To address this need we develop a microscopy approach, multiplex immunofluorescent cell-based detection of DNA, RNA and Protein (MICDDRP), which is based on branched DNA in situ hybridization technology. MICDDRP enables simultaneous single-cell visualization of HIV (a) spliced and unspliced RNA, (b) cytoplasmic and nuclear DNA, and (c) Gag. We use MICDDRP to visualize incoming capsid cores containing RNA and/or nascent DNA and follow reverse transcription kinetics. We also report transcriptional "bursts" of nascent RNA from integrated proviral DNA, and concomitant HIV-1, HIV-2 transcription in co-infected cells. MICDDRP can be used to simultaneously detect multiple viral nucleic acid intermediates, characterize the effects of host factors or drugs on steps of the HIV life cycle, or its reactivation from the latent state, thus facilitating the development of antivirals and latency reactivating agents.

Indexed as

Cell LineCell NucleusDNA, ViralFluoroimmunoassayHIV-1HIV InfectionsHumansRNA SplicingRNA, ViralViral ProteinsDNA, ViralRNA, ViralViral Proteins

Identifiers

PMID29192235
PMCPMC5709414
OpenAlexW2770180107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.